At Abzena, we are committed to providing you with innovative solutions that streamline, and help move your new medicines forward to patients in need. Faster.
Meeting your challenges
Our innovative solutions accelerate your drug program from discovery and development, through to commercialization and launch. No matter the challenge, at all stages, we are always focused on understanding and meeting your program’s goals. Abzena are uniquely positioned, and ready to partner with you, to move your complex biologic or bioconjugate program’s forwards.
Explore our solutions below and see how we can help you accelerate your drug development program.
Explore our innovative solutions
High-yielding platforms that accelerates cell line development.
Explore AbZelect™Next-generation site-specific conjugation linker technology.
Explore ThioBridge™Next-generation in-silico, MAPPS, and immunogenicity assays.
Explore EpiScreen®Advanced analytical platform to expedite IND submission.
Explore LabZient™Design safer, more effective, humanized antibodies.
Find out moreDesign safer, more effective, deimmunized therapeutic proteins.
Find out moreMoving medicine forward.
Whether you’re in need of a specialized solution for a biologic or bioconjugate candidate or have a question about the best strategy for your molecule type, our experts can help.
Meet our experts and ask a question about your drug development challenge today.
Our experience and processes allow us to quickly identify the best drug candidates – the potential winners – for your program, fast. Our agile approach to project management ensures that your drug development programs are delivered on-time and on-budget, mitigating risks, and shortening timescales to IND. Take a glimpse at our early development capabilities and get in touch today.
Featured News + Insights
